Mount Sinai
Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.
In Brief This Week: Mount Sinai, AAVantgarde Bio, Lantern Pharma, Exegenesis Bio, AlveoGene
News items for the weeks of Nov. 25 and Dec. 2, 2024.
In Brief This Week: MD Anderson, Genascence, Seattle Children's Hospital, Abeona, Mount Sinai
News items for the week of Nov. 11, 2024.
Mount Sinai Health Launches Center for Undiagnosed Diseases With $3.3M NIH Grant
Besides making diagnoses, the newest center in the NIH Undiagnosed Diseases Network plans to undertake "research-based characterization" of patients with immunological disorders.
BostonGene, Mount Sinai Partner on Multiple Myeloma Precision Oncology Study
The study will use BostonGene's assays, including whole-exome and whole-transcriptome sequencing, to inform patients' clinical care and advance drug development.
Feb 16, 2022
Jan 3, 2022
Jul 30, 2021
Mar 17, 2021